OKYO Pharma Limited

Historical 13F Holders

Symbol
OKYO
CUSIP
G6724L116
All holders as of
Q2 2026
Type
Equity
Class
SHS NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G6724L116 since 12/18/2024, newest first.

Filer % of Class Filed
Point72 Asset Management, L.P. 13G/A Amendment 1
0% 5/15/2026
Event 3/31/2026
Woodline Partners LP 13G 7.0% 5/15/2026
Event 3/31/2026
Sirenia Capital Management LP 13G
7.7% 5/15/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G
7.9% 2/18/2026
Event 2/17/2026
Chernett Jorey 13G/A Amendment 2 9.5% 2/13/2026
Event 12/31/2025
Dauntless Investment Group, LLC 13G/A Amendment 3 1.2% 2/12/2026
Event 12/31/2025
Dauntless Investment Group, LLC 13G/A Amendment 2 6.3% 11/14/2025
Event 9/30/2025
Chernett Jorey 13G/A Amendment 1 7.8% 11/14/2025
Event 9/30/2025
Laura Natalia Monica Fonda 13G 5.0% 10/29/2025
Event 7/22/2025
Dauntless Investment Group, LLC 13G/A Amendment 1 7.3% 8/5/2025
Event 6/30/2025
Chernett Jorey 13G 6.8% 5/27/2025
Event 5/23/2025
Dauntless Investment Group, LLC 13G 5.9% 3/18/2025
Event 3/12/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 19 6.49 M $9.74 M
2026 Q1 12 6.39 M $10.3 M
2025 Q4 10 665 k $1.15 M
2025 Q3 8 2.57 M $5.14 M
2025 Q2 6 2.77 M $1.48 M
2025 Q1 8 2.08 M $2.63 M
2024 Q4 8 1.03 M $1.18 M
2024 Q3 7 1.00 M $1.02 M
2024 Q2 8 1.01 M $1.21 M
2024 Q1 7 914 k $1.36 M
2023 Q4 9 869 k $1.54 M
2023 Q3 8 95.3 k $176 k
2023 Q2 2 11.9 k $13.7 k